Fredun Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹213.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 32.39 per cent from ₹160.93 crore. This corresponds to a year-on-year *(YoY) growth of 27.26 per cent.
Operating Profit
Operating Profit stands at ₹28.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.64 per cent from ₹26.34 crore. This corresponds to a year-on-year *(YoY) growth of 67.42 per cent.
PBDT
PBDT stands at ₹14.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.75 per cent from ₹15.78 crore. This corresponds to a year-on-year *(YoY) growth of 58.24 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.64 per cent from ₹14.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.96 per cent.
Net Profit
Net Profit stands at ₹10.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.86 per cent from ₹10.48 crore. This represents a 79.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fredun Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Fredun Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fredun Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fredun Pharmaceuticals Ltd Financial Reports
Fredun Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fredun Pharma | 1.15% | 1.78% | 13.42% | 44.49% | 88.44% | 212.11% |
| Amrutanjan Healt | -0.80% | -0.33% | -5.80% | 0.03% | -12.33% | -27.68% |
| Jagsonpal Pharma | 1.21% | -2.56% | 12.47% | 19.29% | 28.49% | 0.09% |
| Shukra Pharma. | 2.10% | 8.78% | 10.66% | 1.83% | -26.08% | 72.65% |
| Syncom Formul. | 2.49% | -1.55% | -0.78% | 3.17% | 6.62% | -25.76% |
| Lincoln Pharma. | -0.35% | -1.72% | -3.87% | 5.78% | 26.05% | 9.38% |
| Fermenta Biotec. | 9.74% | 15.98% | 22.47% | 19.36% | 25.48% | 7.23% |
Company Info
Company Information
Chairman / Executive Director / Joint MD : Daulat N Medhora
Executive Director / Managing Director / CFO : Fredun N Medhora
Independent Non Exe. Director : Daisy Dsouza
Independent Non Exe. Director : Anshu Agarwal
Independent Non Exe. Director : Sonal Desai
Independent Non Exe. Director : Pooja Narendra Sanghavi
Company Sec. & Compli. Officer : Vaishnavi Rajkamal Sahu